Kaempferide inhibited progression of osteoarthritis by targeting the HIF-1 signaling pathway.
10.1097/CM9.0000000000003762
- Author:
Xianjie WEI
1
;
Hesuyuan HUANG
1
;
Ping YUAN
2
;
Peisen XIE
1
;
Keshi ZHANG
1
;
Zhenpeng GUAN
1
Author Information
1. Orthopedics Department, Peking University Shougang Hospital, Beijing 100144, China.
2. Department of Research and Development, Central Laboratory, Peking University Shougang Hospital, Beijing 100144, China.
- Publication Type:Journal Article
- Keywords:
HIF-1 signaling pathway;
IL-1β;
Kaempferide;
NF-κB signaling pathway;
Osteoarthritis
- MeSH:
Animals;
Osteoarthritis/metabolism*;
Signal Transduction/drug effects*;
Rats;
Rats, Sprague-Dawley;
Humans;
Male;
Hypoxia-Inducible Factor 1/metabolism*;
Interleukin-1beta
- From:
Chinese Medical Journal
2025;138(21):2813-2823
- CountryChina
- Language:English
-
Abstract:
BACKGROUND:Osteoarthritis (OA) is a prevalent joint disorder that significantly impairs quality of life among elderly individuals because of chronic pain and physical disability. As the global burden of OA continues to rise, novel therapeutic strategies are urgently needed. Kaempferide (KA), a flavonoid derived from traditional Chinese herbal medicine, is known for its anti-inflammatory properties. However, the effect of KA on the progression of OA has not been well investigated. This study aimed to explore the therapeutic potential of KA in an OA model and investigate the underlying mechanisms via transcriptomic sequencing.
METHODS:An in vitro OA model was established using SW1353 cells treated with interleukin-1 beta (IL-1β) and different concentrations of KA (30, 60, or 90 μmol/L) for 24 h. The anti-inflammatory effects of KA were assessed using quantitative real-time polymerase chain reaction (qRT-PCR), enzyme-linked immunosorbent assay (ELISA), and Western blotting. In vivo , a papain-induced OA rat model was used to evaluate the therapeutic effects of KA through histological and behavioral analyses. Transcriptomic sequencing was performed to explore the differentially expressed genes (DEGs) and related signaling pathways. Statistical analysis was conducted using one-way analysis of variance.
RESULTS:KA significantly increased cell viability in the OA chondrocyte model and downregulated the expression of inflammatory cytokines and cartilage degradation markers, with the greatest reduction observed at 90 μmol/L. In vivo , KA treatment mitigated cartilage degradation and improved gait behavior in OA rats. Transcriptomic analysis revealed substantial modulation of DEGs, implicating the hypoxia-inducible factor-1 (HIF-1) signaling pathway as a key mechanism. Further blocking and rescue experiments revealed that KA regulated key molecules within the HIF-1 pathway, specifically interferon-gamma (IFN-γ) and hypoxia-inducible factor 1-alpha (HIF-1α), confirming their critical roles in mediating the therapeutic effects of KA.
CONCLUSION:KA inhibited the progression of OA by targeting the HIF-1 signaling pathway, reducing inflammation, and cartilage degradation.
